Spotlight On... Covance sets up clinical trial mobile device and app evaluation service; CRISPR software wins SXSW gong; Servier picks IMS platform for Russian venture; and more...

Covance has begun helping companies certify the accuracy and consistency of their mobile clinical trial devices and apps. The service is designed to guide companies through the process of selecting the mobile tools that will enable them to gather clinical trial data. "Covance has the expertise and scale to help our partners evaluate which apps and devices will be most effective," CEO Deborah Keller said in a statement. Release | More from FierceCRO

> Desktop Genetics won a SXSW Interactive Innovation Award for its CRISPR software. Release

> Servier's Russian subsidiary began using IMS Health's CRM. Post

> Critical Outcome Technologies introduced a system to guide cancer treatment decisions. News

> Veeva Systems ($VEEV) rolled out its OpenData system in 12 more countries, bringing the total up to 35. More

> Advera Health unveiled a tool for analyzing clinical trial data and real-world evidence for drugs. Item

> BDI Pharma and TraceLink began pitching their Drug Supply Chain Security Act-compliant system. More

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.